SEI Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

SEI Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,207	Closed	-$115K	–	3479
2018 Q2	$115K	Sell	1,207 -167	-12%	-$15.3K	﹤0.01%	2239
2018 Q1	$120K	Buy	1,374 +132	+11%	+$12.1K	﹤0.01%	2068
2017 Q4	$105K	Sell	1,242 -160	-11%	-$13.4K	﹤0.01%	2127
2017 Q3	$122K	Buy	1,402 +174	+14%	+$13.9K	﹤0.01%	2025
2017 Q2	$95K	Buy	1,228 +28	+2%	+$1.99K	﹤0.01%	2081
2017 Q1	$83K	Hold	1,200	–	–	﹤0.01%	1996
2016 Q4	$71K	Hold	1,200	–	–	﹤0.01%	2046
2016 Q3	$80K	Buy	1,200 +600	+100%	+$37.1K	﹤0.01%	1930
2016 Q2	$32K	Buy	+600	New	+$32.9K	﹤0.01%	2049

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

SEI Investments's XBI Position: Q3 2018 in Review

SEI Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2018, closing a stake of 1,207 shares — an estimated $115K sold.

SEI Investments first reported a position in XBI in Q2 2016 and held it in 9 quarters. The position peaked at $122K in Q3 2017. 432 funds tracked by Wall St. Rank hold XBI as of Q3 2018.

SEI Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2018 after selling out during the quarter.
SEI Investments sold 1,207 State Street SPDR S&P Biotech ETF shares in Q3 2018, an estimated $115K.
SEI Investments first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 9 quarters.
SEI Investments's State Street SPDR S&P Biotech ETF position peaked at $122K in Q3 2017.
432 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.